Literature DB >> 19629533

Prevention of catheter-related bacteremia in children on hemodialysis: time for action.

Constantinos J Stefanidis1.   

Abstract

This editorial commentary discusses the strategies for prevention of catheter-related bacteremia (CRB) in children on hemodialysis, which is associated with high morbidity and the increase of hospital cost. There is evidence that the use of arteriovenous fistulae in children on hemodialysis is associated with lower infection rates. Therefore, the use of catheters in these patients should be decreased by improving arteriovenous fistulae use rates or by increasing peritoneal dialysis patient recruitment. However, despite the wide adoption of such policies, hemodialysis catheters are still being used in a significant number of cases. For these patients, implementation of effective strategies for preventing contamination of the catheter hub should be a priority. The appropriate recording and evaluation of CRB rates are important for assessing preventive policies. In addition, the successful management of a CRB is essential for preventing recurrence of bacteremia. Recently it was documented in a number of randomized clinical trials that antimicrobial lock solutions were effective for preventing CRB. It is suggested that the use of antimicrobial locks should be considered in children who are at high risk of developing CRB, with caution for their long-term use, because of the possibility of bacterial resistance. Now is the time for action, and all preventive steps should be performed simultaneously to minimize the risk of CRB.

Entities:  

Mesh:

Year:  2009        PMID: 19629533     DOI: 10.1007/s00467-009-1254-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  78 in total

1.  Bacterial infections in hemodialysis patients: pathogenesis and prevention.

Authors:  Bertrand L Jaber
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

2.  Why is it that internists do not follow guidelines for preventing intravascular catheter infections?

Authors:  Lewis Rubinson; Albert W Wu; Edward E Haponik; Gregory B Diette
Journal:  Infect Control Hosp Epidemiol       Date:  2005-06       Impact factor: 3.254

3.  Systemic anticoagulation and bleeding in children with hemodialysis catheters.

Authors:  Michael L Moritz; Abhay Vats; Demetrius Ellis
Journal:  Pediatr Nephrol       Date:  2002-11-21       Impact factor: 3.714

4.  Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial.

Authors:  Anil K Saxena; Bodh R Panhotra; Dasappan S Sundaram; Mohammed Naguib Fahmy Morsy; Ali M Al-Arabi Al-Ghamdi
Journal:  Nephrology (Carlton)       Date:  2006-08       Impact factor: 2.506

5.  Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock.

Authors:  Anil K Saxena; B R Panhotra; Mohammed Naguib
Journal:  Pharmacotherapy       Date:  2002-01       Impact factor: 4.705

6.  Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Anthony Billings; Nancy Simon; JoAnn Gonzalez; Denise Francoeur; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2009-07-10       Impact factor: 3.714

7.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

8.  Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.

Authors:  J R Boelaert; H W Van Landuyt; C A Godard; R F Daneels; M L Schurgers; E G Matthys; Y A De Baere; D W Gheyle; B Z Gordts; L A Herwaldt
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

9.  A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters.

Authors:  David Wayne Johnson; Robert MacGinley; Troy David Kay; Carmel Mary Hawley; Scott Bryan Campbell; Nicole Maree Isbel; Peter Hollett
Journal:  Nephrol Dial Transplant       Date:  2002-10       Impact factor: 5.992

10.  Use of prophylactic topical or intraluminal antibiotics for hemodialysis catheters.

Authors:  Michele H Mokrzycki
Journal:  Nat Clin Pract Nephrol       Date:  2008-07-22
View more
  3 in total

1.  Chronic hemodialysis in children weighing less than 10 kg.

Authors:  Catherine Quinlan; Marie Bates; Aishling Sheils; Niamh Dolan; Michael Riordan; Atif Awan
Journal:  Pediatr Nephrol       Date:  2012-12-22       Impact factor: 3.714

2.  Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative.

Authors:  Olivera Marsenic; Jonathan Rodean; Troy Richardson; Sarah Swartz; Donna Claes; J Christopher Day; Bradley Warady; Alicia Neu
Journal:  Pediatr Nephrol       Date:  2019-10-25       Impact factor: 3.714

Review 3.  Biology of sepsis: its relevance to pediatric nephrology.

Authors:  Neal B Blatt; Sushant Srinivasan; Theresa Mottes; Maureen M Shanley; Thomas P Shanley
Journal:  Pediatr Nephrol       Date:  2014-01-10       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.